Margot Vandenbossche’s Post

The healthcare world is buzzing about digital therapeutics (DTx) as a game-changer. Pharma is jumping on board, seeing DTx's power to boost patient outcomes and set their products apart. But, to succeed long-term, a strategic approach is critical in this complex, fast-changing market. Are you interested in getting to know our 5-stage framework for developing resilient and scalable DTx solutions? https://lnkd.in/dFhJVdRD #DigitalTherapeutics #DTx #HealthcareInnovation #PharmaStrategy

The rapid growth of digital therapeutics (DTx) has outpaced the ability of healthcare systems to adapt, leading to challenges in market adoption. Ipsos' latest article delves into the world of digital therapeutics and presents Ipsos' 5-stage framework for developing resilient and scalable DTx solutions. Download the article now and explore how to unlock the full potential of DTx in pharma. https://lnkd.in/gVQTfJEJ   #DigitalTherapeutics #DTx #HealthcareInnovation #PharmaStrategy 

As pharma companies increasingly try to incorporate DTx into their strategies, they face challenges in navigating regulatory uncertainty and slow adoption rates. In our latest article we explore the complex world of digital therapeutics and present Ipsos' 5-stage framework for developing resilient and scalable DTx businesses. Please do message me or Francine Fram if you would like any further information. #DigitalTherapeutics #DTx #HealthcareInnovation #PharmaStrategy

As pharma companies increasingly try to incorporate Digital therapeutics (DTx) into their strategies, they face challenges in navigating regulatory uncertainty and slow adoption rates. Our latest article explores the complex world of digital therapeutics and presents Ipsos' 5-stage framework for developing resilient and scalable DTx businesses. Download the full article to discover key insights and strategies for success in this rapidly evolving industry. https://lnkd.in/dwG9NNt5 #DigitalTherapeutics #DTx #HealthcareInnovation #PharmaStrategy

How can pharma companies navigate this complex landscape and build sustainable DTx businesses? Our latest article delves into the world of digital therapeutics and presents Ipsos' 5-stage framework for developing resilient and scalable DTx solutions. Download the article now and explore how to unlock the full potential of DTx in pharma. https://lnkd.in/eKxNnxG2 #DigitalTherapeutics #DTx #HealthcareInnovation #PharmaStrategy

📢 Exciting Developments in Digital Therapeutics (DTx) 🚀 Pharmaceutical companies are recognizing the potential of Digital Therapeutics (DTx) to transform healthcare. These evidence-based digital interventions are set to revolutionize the way we prevent, manage, and treat various conditions. 🌐💊 However, the rapid growth of DTx has outpaced the ability of healthcare systems to adapt, leading to regulatory challenges and slow adoption rates. In our latest article, we dive deep into the complex landscape of DTx and the hurdles faced by companies in this space. 🔍 Discover Ipsos' 5-stage framework for developing a resilient and scalable DTx business. Their insights are designed to help you navigate the intricacies of this emerging field and harness its full potential. 📅 Published on June 17, 2024 Read the full article here: A Dose of Digital: Can Pharma Make DTx a Healthy Business? https://lnkd.in/e7B-pAM4 Authored by: Francine Fram, Head of Forecasting, Data Science CoE, Healthcare Svetlana Gogolina, Chief Research Officer, Head of Data Science, Healthcare #HealthcareInnovation #DigitalTherapeutics #DTx #Pharma #IpsosInsights #HealthcareRevolution #DigitalHealth

MARKET ACCESS RESEARCH: Prescription digital therapeutics will see increased activity by 2025, with 47 percent of #payers, #IDNs, and other stakeholders planning to execute #PDT strategies by then, according to our Second Annual Market Access Survey. “Organizations desire additional clarity regarding the value of prescription therapeutics and reimbursement,” said Valuate Principal Tony Gibson, who supervised the survey. “CMS and FDA activity in this area will also spur payer planning in this area.” In addition to the PDT activity, 40 percent of respondents say they will execute #AI plans by 2025 for administrative and manual functions, including streamlining #priorauthorization. The next AI frontier may focus on patient engagement and patient decision-making tools, respondents say. #marketaccess #pharma #biotech

Can Pharma Make Digital Therapeutics (DTx) a Healthy Business? 💊   Interesting Ipsos report published yesterday by Svetlana Gogolina and Francine Fram, highlighting the continued opportunity for both these industries to support each other!   Hopefully, pharma can help with regulatory and reimbursement hurdles, and DTx can help further innovate when it comes to improving patient outcomes...

From enabling advanced therapies to further improving cost efficiencies, outsourcing is unlocking new potential for growth and improvement across the pharma space. Read more from John Maldonado and Advent's expert team on this and other top trends shaping the pharma space in our ultimate guide: https://lnkd.in/eH_W3x2h

Digital therapeutics and medicines (#DTx) are gaining recognition as potential treatments for conditions that have significant unmet medical needs. However, the regulatory environment for these #digitalhealth products is becoming more complex and evolving rapidly. This puts pressure on developers of digital medicines to meet expectations for innovative solutions and bring them to market faster while generating substantial revenue. To navigate this industry sector and track the evolution of these products, the FDA is seeking to partner with DTx manufacturers. Staying up-to-date with these initiatives and testing go-to-market models will help developers strategically plan and handle changing conditions and competition. In this webinar from Premier Consulting, Robb Lawrence, Senior Vice President of Commercial Strategy, provides key insights into leveraging regulatory pathways and highlight factors that will ultimately determine the commercial success or failure of digital products currently in development.